Microsimulation models are becoming increasingly common in the field of decision modeling for health. Because microsimulation models are computationally more demanding than traditional Markov cohort models, the use of computer programming languages in their development has become more common. R is a programming language that has gained recognition within the field of decision modeling. It has the capacity to perform microsimulation models more efficiently than software commonly used for decision modeling, incorporate statistical analyses within decision models, and produce more transparent models and reproducible results. However, no clear guidance for the implementation of microsimulation models in R exists. In this tutorial, we provide a step-by-step guide to build microsimulation models in R and illustrate the use of this guide on a simple, but transferable, hypothetical decision problem. We guide the reader through the necessary steps and provide generic R code that is flexible and can be adapted for other models. We also show how this code can be extended to address more complex model structures and provide an efficient microsimulation approach that relies on vectorization solutions. Healthcare policy makers are often faced with decisions on how to allocate healthcare resources given constrained budgets and the continuous development of new, expensive technologies. Policy makers increasingly rely on health decision modeling tools to guide their decisions, as such models can synthesize evidence from different sources to give indications on the long-term implications and the uncertainty around a decision.
models is that the transition probabilities only depend on the current health state at any given cycle and cannot depend on the history before that cycle. This is often referred to as the ''Markov'' assumption and is an inherent limitation of cohort models. 4 Although this assumption can be relaxed by creating additional states that can capture the cohort's history, this can result in difficult to manage models due to ''state explosion''. 4 Individual-based state-transition (or microsimulation) models address many of the limitations of deterministic cohort models because they can more accurately reflect individual clinical pathways, incorporate the impact of history on future events, and more easily capture the variation in patients' characteristics at baseline. 5, 6 Microsimulation models differ from the more traditional cohort-based models because they simulate the impact of interventions or policies on individual trajectories rather than the deterministic mean response of homogeneous cohorts. 3, [7] [8] [9] [10] [11] In a microsimulation model, outcomes are generated for each individual and are used to estimate the distribution of an outcome for a sample of potentially heterogeneous individuals. This individual-level simulation allows the inclusion of stochastic variation in disease progression as well as variation due to individual characteristics. Microsimulation models do not require the Markov assumption and so can introduce ''memory'' to the models' structure. This ''memory'' characteristic makes microsimulation models more popular in diseases where the severity of the disease or the cost and health outcomes vary with duration spent in a diseased state. 12 There have been numerous microsimulation models developed for health applications. For example, the Population Health Model (POHEM) simulates the lifecycle of the Canadian population and assesses the impact of policy and program interventions on the health status of Canadians; [13] [14] [15] the Future Elderly Model (FEM) predicts the impact of changes in health care status on future health and costs; 16 and the Prostate Cancer and Policy (PCOP) model evaluates the benefits and harms of prostate cancer screening. 17 A drawback of the additional functionality of microsimulation models is numerical and computational complexity. To accommodate the computational demands of microsimulation models, health decision scientists increasingly adopt (high-level) programming languages. The increasing availability of patient-level data also requires more advanced statistical analyses to be integrated with microsimulation models. In addition, computational efficiency can be achieved in decision modeling when relying on numerical and statistical computing software, such as Matlab or R, versus either spreadsheet software (e.g., Microsoft Excel) or common specialized software, such as TreeAge. 18 Recently, we illustrated the increased use of the statistical software R in health decision sciences, and provided a collection of resources for its application in medical decision making. 19 R is an open-source and freely available software environment, where statistical analyses can be combined with decision models within the same framework, and the results can be presented in publication-ready tabular and graphical forms. 20 The popularity of R in decision analysis follows similar trends as in other fields of science, which have established R as the second-most often used statistical software 21 and among the most often used programming languages.
22 Implementing a microsimulation model using a programming language provides the ability to use version control capabilities and repositories, such as GitHub. This is particularly useful when collaborating in teams, where multiple members can contribute to different components of the model. Additionally, with R, it is possible to use tools to generate web-based apps and graphical user interfaces (e.g., Shiny). 19 R is not a programming language that was developed with a focus on computational performance. Nevertheless, there are some characteristics of the R programming language that can be leveraged to allow R-coded programs to perform efficiently. A key attribute of R is its ability to process problems more efficiently when presented in a vector rather than in a scalar format. Vectorization can reduce the need to rely on iterative ''for'' loops, which, in general, increase computation time significantly. Vectorization is particularly important in decision analysis, because processes are frequently repetitive and relatively straightforward to vectorize.
Despite the growing popularity of statistical programming for building simulation models in health decision sciences, few educational tutorials on how to perform these simulations are available. 12, 23, 24 This tutorial offers both a theoretical and applied introduction on building microsimulation models in R, and has been created for beginner/intermediate users of R who are interested in developing an R-based microsimulation model. This tutorial is structured as follows: First, we introduce a conceptual algorithm for model implementation, which can be applied to any (high-level) programming language, such as R. Subsequently, we illustrate how to build a microsimulation model in R using a simple, hypothetical decision problem. We guide the reader through the necessary steps and provide the R code used in the illustration. We additionally present a microsimulation solution that uses a vectorization approach. We then conclude with a discussion of the advantages and disadvantages of using R for microsimulation modeling, and provide guidance on how to extend the presented methods to more complex applications. In Supplementary Appendices and on GitHub (https:// github.com/DARTH-git/Microsimulation-tutorial), we provide the full R code used to run the microsimulation model and the vectorized approach.
Methods
Microsimulation models are structured around a set of mutually exclusive and collectively exhaustive health states. 9, 10, 25, 26 Each hypothetical individual can only be in one health state at any given cycle. Based on individual-specific transition probabilities, individuals are simulated through the model one at a time, while keeping track of their individual trajectories. In an economic evaluation framework, each health state, and potentially each transition between health states, is associated with a particular cost and health outcome value. For example, in the context of a cost-utility analysis, the cost and health outcome values would, respectively, represent the cost and the quality-adjusted life years (QALYs) associated with remaining in each health state for one cycle. Both state and transition outcome values can depend on the individual's characteristics as well as on the past transitions and events of the individual.
State-transition Microsimulation Algorithm
The flexibility of a programming language like R implies that a microsimulation model can be implemented in multiple ways depending on the experience and programming style of the modeler and the research question that needs to be addressed. Below, we outline an algorithm that could be used when implementing a microsimulation model. This algorithm serves our goal to provide a generic approach with a reasonable balance between clarity and efficiency. First, we outline the steps to simulate one hypothetical individual over time.
The individual starts the simulation in an initial
health state and is assigned a cost and health outcome value associated with staying in this initial state for one cycle, taking into consideration any individual-level characteristics. 2. During each cycle, the individual's probability to transition to a different health state (or remain in the current health state) in the next cycle is assigned based on the health states previously occupied and the individual's characteristics. 3. The health state to which the individual will transition to in the next cycle is sampled from a categorical distribution based on the probability of transitioning to each possible health state. The individual will then either transition to a new health state or remain in the same health state at the end of the cycle. Repeating these steps for all individuals in the simulation, allows us to describe the distribution of total cost and health outcomes for the population of interest.
To formalize the previous steps, we define the following notation nt as the number of discrete time cycles t as the current cycle, ranging from 0 to nt cl as the cycle length ni as the number of individuals i as a specific individual from the group of individuals nx as the number of individual characteristics ns as the number of health states n as the ns character vector of health state names p as the ns vector containing the transition probabilities for individual i at the end of cycle t M as the ni 3 (nt + 1) matrix capturing the health states occupied by all individuals during all cycles X as the ni 3 (nt + 1) 3 nx 3-dimensional array of individuals' characteristics for all cycles (e.g. age, gender, disease severity, comorbidities) ProbsðM i ; X i Þ; CostsðM i ; X i Þ; EffsðM i ; X i ; clÞ as functions assigning individual-specific probabilities, cost and health outcome values conditional on M i , X i and cl. M i and X i represent the vectors of health states and individual characteristics, respectively, for all time points for individual i C as the ni 3 (nt + 1) matrix capturing the costs for all individuals during all cycles E as the ni 3 (nt + 1) matrix capturing the health outcomes for all individuals during all cycles dwc as the nt vector of discount weights for costs, where dwc = 1
dwe as the nt vector of discount weights for health outcomes, where dwe = 1 (1 + de) t , with de being the discount rate for the health outcome values at any cycle t. The first cycle is not discounted, as the first time point t is equal to zero.
tc as the ni vector of total (discounted) costs for all individuals te as the ni vector of total (discounted) health outcomes for all individuals Below, we present an algorithm that can be used to perform a state-transition microsimulation. The enumerated areas on the left correspond to the steps of the microsimulation algorithm outlined before.
for i = 1 to ni do M i0 is assigned the initial health state for individual i. The implementation of the microsimulation algorithm using R syntax is illustrated in Box 1. The notation in Box 1 follows the algorithm outlined before with inner product multiplication indicated in R by the ''%*%'' symbol. Because t starts at 0, we increment t by 1 to correspond to the element index in the vectors and matrices in R. Variable names for matrices are preceded by the prefix ''m.'', whereas, for vectors, the prefix ''v.'' is used. At each individual and each cycle, the vector of probabilities ''v.p'' is replaced with a new set of transition probabilities. The Probs() function returns a vector of state transition probabilities. Finally, both Costs() and Effs() functions yield a single value of the cost and health outcomes per individual per cycle. Box 1 A generic implementation of the microsimulation algorithm outlined before using R syntax. The R variable names are defined in Table 1 .
The algorithm in Box 1 illustrates the microsimulation process for one treatment strategy. In cases where 2 or more strategies are compared, the algorithm should be completed separately for each strategy with strategyspecific values. The vectors of undiscounted total costs and health outcomes per individual can be calculated by setting dc and de equal to zero. The approach above can be readily expanded or simplified. For example, in the context of a cost-utility economic evaluation, the QALYs accumulated within a cycle would be captured in the health outcome matrix E and, consequently, te would capture the total QALYs across all cycles. In extension, tc and te, the mean of individual-specific costs and QALYs for each strategy, respectively, could be calculated to generate standard incremental cost-effectiveness tables.
Stochastic Variation and Random Sampling in Microsimulation Models
Microsimulation models rely on Monte Carlo (MC) simulation methods to describe the stochastic transition process of individuals through the model. 27 Due to this stochastic process, the estimates of a microsimulation will be different between individuals. Therefore, executing the model for a sufficiently large number of individuals is important to achieve a representative distribution of population outcomes. The variability around the mean model estimate is called Monte Carlo Standard Error (MCSE). In a decision problem that could be described with either a microsimulation or a cohort model, the 2 models types should yield the same estimates as the number of simulated individuals in the microsimulation model increases. 28, 29 In this tutorial, we use graphical diagnostics to show how outcomes produced using a microsimulation model converge to those produced using a cohort model. One such example is a plot of the mean simulation estimates as a function of the number of individuals run in the microsimulation model (i.e., microsimulation sample size).
When designing a microsimulation model for comparative effectiveness or cost-effectiveness purposes, it is important that simulated individuals are as similar as possible across comparators, except for the intervention to which they are exposed. One can think of the random sampling process as 2 parallel processes, where the same hypothetical individual is exposed to both the intervention and the control. This can be achieved by using pre-sampled values from the distributions used in the model, by explicitly setting a seed number per individual. 30 This ensures that individuals across intervention scenarios share the same baseline characteristics, and reduces any difference observed between the intervention scenarios that can be attributed to MC variability and not to intervention allocation. An additional benefit of setting the seed is that it allows the results to be reproducible despite the inherent stochastic process.
Example: The Sick-Sicker Model
In this section, we illustrate the implementation of the algorithm presented above, using a previously published decision model. 31 This illustration provides an example of how R can be used for the development of a microsimulation model for a specific disease process. We intend for the R code below to be generic to allow it to be customizable. There are many opportunities to improve the efficiency of the code for specific applications but the goal here is to provide a generic code as a starting point.
The illustration relies on a state-transition cohort model of a hypothetical disease (the Sick-Sicker model), first described by Enns et al. 31 We initially create a microsimulation implementation of the Sick-Sicker cohort model and subsequently extend it to illustrate the advantages of microsimulation models in incorporating individual-level characteristics and ''memory'' in the disease process. The Sick-Sicker model consists of 4 health states: healthy (H), sick (S1), sicker (S2) and dead (D) ( Figure 1 ). All individuals are assumed to be healthy at baseline. Over time, healthy individuals face a risk of developing the disease and progressing to S1. Individuals in S1 can recover (return to state H), stay in S1, progress further to S2 or die. Individuals in S2 cannot recover (i.e., cannot transition to either S1 or H). Individuals in H are assumed to have a fixed mortality rate. Individuals in S1 and S2 have an increased mortality rate compared with healthy individuals. All individuals are followed for 30 years using annual cycles. This cycle length of 1 year is assumed to be constant throughout the model's time horizon.
We evaluate 2 alternative strategies: a no-treatment and a treatment strategy. The treatment improves utility for those individuals in the S1 state but has no impact on utility for those in the S2 state. However, due to the nature of this hypothetical disease, we are not able to distinguish those who are in S1 from those in S2. Therefore, under the treatment strategy, individuals who occupy states S1 or S2 receive treatment and continue doing so until they recover to the healthy state or die.
In the extension of the model that incorporates ''memory'' and individual-level characteristics, 3 modifications are made to the model. Firstly, we assume that the benefits of treatment wane over time, with the utility of those in S1 on treatment decreasing by 0.03 every year they spend in S1. The second modification involves the dependency of mortality rates on the duration of remaining in the disease states (a 20% increase every cycle in S1 or S2). Finally, we also assume that the improvement on quality of life by the treatment varies across individuals through a characteristic that acts as a treatment effect modifier. All model parameter values and R variable names are presented in Table 1 .
The probabilities to die when sick (p.S1D) and sicker (p.S2D) are calculated by converting (p.HD) the probability to die when healthy) to a rate, multiplying it by the rate ratios rr.S1 and rr.S2, respectively, and then converting them back to a probability. In the extended model, not only the rate ratios but also the variable rp.S1S2 and the duration of being sick are used to adjust the rates. See the R code below for more details on the calculations.
In the next section, we provide the R code and some documentation for the most important steps of the algorithm. We first illustrate the direct microsimulation implementation of the Sick-Sicker model and then provide the modifications necessary to extend the model to the scenario where ''memory'' is incorporated in the model. A full working version of the R codes used for each decision model can be found in the Appendices and on GitHub. 
Microsimulation Implementation of the SickSicker Model
The R code is broken down into 3 sections: the model input section, the model's main section, and the model output section. In the model input section, input parameters are loaded into the R environment. We assume that the health state of the individuals is known at the start of the simulation, and stored in the variable v.M_1. In our example, all individuals enter the model as healthy (i.e., at health state (H)).
First, we specify the number of individuals, their initial state, the time horizon, the health states, the discount rates, and the intervention strategies. ru.S1S2 0.03 -Proportional increase of the mortality rate with every additional year of being sick/sicker (S1 and S2)
The next lines of R code specify the transition probabilities, cost, and the utility input for individuals in the treatment and the no-treatment group (Table 1) .
# Transition probabilities (per cycle)
p.HD <-0.005 # probability to die when healthy p.HS1 <-0.15 # probability to become sick when healthy p.S1H <-0.5 # probability to become healthy when sick p.S1S2 <-0.105 # probability to become sicker when sick r.S1 <-3 # rate ratio of death when sick vs healthy r.S2 <-10 # rate ratio of death when sicker vs healthy r.HD <--log(1 -p.HD) # rate of death when healthy r.S1D <-rr.S1 * r.HD # rate of death when sick r.S2D <-rr.S2 * r.HD # rate of death when sicker p.S1D <-1 -exp(-r.S1D) # probability to die when sick p.S2D <-1 -exp(-r.S2D) # probability to die when sicker # Cost and utility inputs In the model's main section, we define 4 R functions that constitute the core of the microsimulation model. In the following paragraphs, we describe each component of these 4 functions. The main function is the MicroSim() function, which operationalizes the algorithm steps described above in R, adjusted to represent the Sick-Sicker model. The MicroSim() function includes arguments that control the input parameters (e.g., names of health states) and the components of the model itself (e.g., the seed number). It also provides the option to the modeler to record the transitions between states at every cycle in a TS matrix of size ni 3 (nt + 1) and the calculation of a microsimulation trace TR, which captures the proportion of individuals occupying each state at every cycle. Some arguments have a default setting, which means that, in case the user does not specify them, they will be assigned a default value (e.g., the arguments TR.out and TS.out that control whether a microsimulation trace and a transition array will be calculated are by default set to TRUE and the default seed number is 1). The Trt argument is a scalar with a Boolean value (by default set to FALSE), used to run the Sick-Sicker model for a group of treated or non-treated individuals. In other situations, modelers can adjust the code to make use of a vector with Boolean values to model mixed groups of treated and non-treated individuals. The following paragraphs describe each component of the MicroSim() function. The R code lines below describe the arguments and functions used in the MicroSim() function. In addition to the MicroSim() function, we construct 3 functions that need to be specified and executed before execution of the MicroSim() function. These are the Probs(), Costs() and Effs() functions, which are used to update the probabilities, costs, and health outcome values at each cycle, respectively. We will provide more details on these functions later in this tutorial. Within the MicroSim() function, 2 vectors with discount weights are generated based on the discount rates for costs and health outcomes, respectively, d.c and d.e, specified in the argument section of the function. The first cycle is not discounted. In R, variables used to store information across iterations need to be initialized and their dimensions need to be declared outside of the iterative process. Hence, we first initialize the variables that will capture the matrices M, C, and E. m.M <-m.C <-m.E <-matrix(nrow = n.i, ncol = n.t + 1 , dimnames = list(paste("ind", 1:n.i, sep = " "),
paste("cycle", 0:n.t, sep = " ")))
Next, we specify the health states the individuals occupy at the start of the simulation. Given M i0 , we can calculate C i0 and E i0 for every individual i and store this information in m.C and m.E. At the beginning of all the subsequent cycles t, the transition probabilities v.p, given the states occupied at the beginning of the cycle, are specified. The states M it occupied by any individual i are sampled from a categorical distribution with frequency based on v.p. The next step is to calculate C it and E it for each individual i during each cycle t. The costs and QALYs only depend on the current state of the individual and on whether they are receiving treatment or not. Note that m.C and m.E are initialized, whereas v.p is not, as we are not interested in storing it for every iteration and it will therefore be overwritten at every cycle. The following lines of code display the progress of the simulation. Once the iterative process is completed, the model's output is captured in the initialized variables. To calculate the (discounted) total costs and QALYs per individual across all cycles, we take the inner products of C and E with the discount weight vectors. The average total costs and QALYs within this patient population are estimated by averaging across the individual total costs and QALYs.
tc <-m.C %*% v.dwc # total (discounted) cost per individual te <-m.E %*% v.dwe # total (discounted) QALYs per individual
The function MicroSim() also offers the modeler the option to generate a microsimulation trace matrix TR and a matrix of transitions TS (i.e., argument set to TRUE). Key components in any microsimulation structure are the functions used to update the transition probabilities and to estimate the costs and health outcomes for every cycle. Below, we present the R code used to describe these functions for the Sick-Sicker model. The Probs() function is used to update transition probabilities based on the health state occupied at cycle t, as represented in Figure 1 . The M_it argument in the context of the Sick-Sicker model represents a single character, representing the health state for individual i at cycle t, extracted from the m.M matrix. In this simple example where there is no time variation in the transition probabilities, one could specify a transition probability matrix and rely on linear algebra to simplify the function Probs(). At the end of the function, there is a check that all probabilities sum to one. If this condition is not met, an error message appears. In this example, the function Costs() depends on the current health state and treatment status of the individual. Individuals occupying states S1 and S2 have higher costs if treated compared to untreated individuals. If Trt is set to TRUE, the function will estimate the costs for the treatment strategy; otherwise, the costs for the no treatment group are estimated. The function Effs() is used for the estimation of the health outcomes, QALYs in our example, during each cycle based on the current health state. If Trt is set to TRUE, the function will estimate the QALYs for the treatment strategy; this means that all individuals in the sample are treated when sick or sicker, otherwise the QALYs for the no treatment group are estimated. The variable cl indicates the cycle length. 
Results of the Simple Sick-Sicker Microsimulation
After all the functions and parameters are defined, the MicroSim() function is executed and the outcomes are stored in the lists named sim_no_trt and sim_trt for the no-treatment and treatment strategies, respectively. The outcomes stored in these lists are useful to generate graphical representations of individuals' trajectories between health states over all cycles. Figure 2 shows the trajectories of 3 individuals of the Sick-Sicker model. The variation between the individual trajectories is the result of the stochastic nature of the microsimulation model. For example, an individual can stay healthy during the first 4 cycles, can become sick during cycle 5, and become sicker during cycle 6. From cycle 6 until 16, the individual remains in the sicker state and during cycle 17 the individuals dies (see top trajectory Figure 2 ). The cost and QALY outcomes for these 3 individuals across the time horizon are represented in graphical form in Figure 3 .
Because this model was developed to answer an economic evaluation question, we need to calculate the incremental costs (DC), QALYs (DE), and the incremental costs effectiveness ratio (ICER). The code below performs these calculations and stores the values in a table. The table_micro variable includes the costs and QALYs per strategy, the incremental costs and QALYs, and the ICER of the treatment strategy. Table 2 presents the results of the cost-effectiveness analysis using the microsimulation model for a sample size of 10,000 and 100,000 individuals. For comparison purposes, the results based on the deterministic cohort model are also presented (R code in Supplementary Appendix C). We can observe that the microsimulation model and the cohort model produce almost identical results after a large number of simulations. Because microsimulation models generate outcomes for each individual, it is possible to observe the distribution of the outcomes (costs and QALYs) by creating histograms (Figure 4 ).
Comparing Microsimulation to Cohort Model Outcomes
Outcomes from microsimulation models where no ''memory'' and no heterogeneity at baseline across individuals is assumed should asymptotically converge to those from a deterministic cohort model as the number of individuals simulated in the microsimulation model increases. 11, 28, 29 The number of hypothetical individuals that need to be generated is related to the magnitude of the MCSE. In Figure 5 , we present the proportion of individuals occupying each health state at every cycle of both the microsimulation model and the cohort model. As illustrated in Figure 5 , the microsimulation trace converges to the Markov cohort trace as the number of simulated individuals increases.
In addition, the Markov and microsimulation costeffectiveness outcomes traces are graphically presented to illustrate the convergence of the microsimulation model to the outcomes derived using a cohort representation of the model (Figure 6 ).
Methods: Adding Memory to the Sick-Sicker Model
In this section, we highlight 2 of the advantages of using a microsimulation implementation of a cohort model, which are to incorporate 1) 'memory' into the disease dynamics, and 2) variation in the baseline characteristics for every individual. To illustrate this, we extend the Sick-Sicker microsimulation model to include memory effects and patient heterogeneity at baseline. Specifically, we assume that mortality rate increases the longer a patient spends in one of the sick states ( Figure 1 and Table 1 ) and that effectiveness of treatment is dependent on the duration of stay in the sick states and on baseline characteristics. Below, we outline the modifications and additions that are necessary to incorporate these changes to the model. Supplementary Appendix B includes the complete R code used to build the ''extended'' microsimulation model. All microsimulation results were generated by setting the random seed to 1 at the beginning of the simulation. Monte Carlo standard error in brackets. Figure 4 Histograms of the individual costs (top) and individual QALY (bottom) outcomes for the no-treatment strategy for the simple microsimulation model (n = 100,000). We initially assume that individuals in our cohort have a baseline characteristic that acts as an effect modifier to the treatment effect. This baseline characteristic x is assumed to follow a uniform distribution within the population of interest. To include this extra variable, the MicroSim() function in the extended model has an extra argument X. This argument is assigned the name of the vector or matrix capturing any individual characteristics.
Additionally, we introduce 2 new variables-the annual increase in mortality rate (rp.S1S2) and the annual decrease in utility for treated sick patients (ru.S1S2)-with every additional cycle spent in the sick states (S1 or S2).
rp.S1S2 <-0.2 # increase of the mortality rate with every additional year being sick/ sicker ru.S1S2 <-0.03 # decrease in utility of treated sick individuals with every additional year being sick/sicker Subsequently, we introduce the help variable dur, which stores the number of consecutive cycles the individual remains in either S1 or S2. Because every individual starts in the healthy state, the dur variable takes the value 0 at cycle 0. With every additional cycle that an individual spent in S1 or S2, a value of 1 is added to dur. When the individual recovers (transitions back to state H), the dur variable is set again to zero. This means that all previous cycles spent in one of the sick health states does not influence the current transition probabilities. The process is repeated every time an individual transitions to S1. We introduce minor modifications on the Probs() function to take the history of the individual into account when updating the probability of transitioning to death from S1 and S2. The modified function is presented below. r.S1D <--log(1 -p.S1D) r.S2D <--log(1 -p.S2D) p.S1D <-1 -exp(-r.S1D * (1 + dur * rp.S1S2)) # calculate p.S1D conditional on duration of being sick/sicker r.S2D <-1 -exp(-r.S2D * (1 + dur * rp.S1S2)) # calculate p.S2D conditional on duration of being sick/sicker 
Results of the Extended Sick-Sicker Model
The cost-effectiveness analysis based on the extended microsimulation model is presented in Table 3 . The expected costs, QALYs, and ICER of this simulation are lower in both the no-treatment and treatment strategy compared with the simple microsimulation (and cohort model) ( Table 2 and Table 3 ).
The results are consistent with the modifications that were applied to the model. With an increasing probability of death for each additional year spent in the sick health states, patient life-expectancy is reduced, resulting in fewer QALYs as well as lower healthcare costs. The gains in QALYs due to treatment are also reduced compared with the simple model due to the decreasing effectiveness of treatment over time in the extended model. The microsimulation traces presented in Figure 7 confirm the increased mortality rate. Finally, the uncertainty around the health outcomes, QALYs, has increased due to the introduction of the treatment effect modifier.
Vectorized Implementation of the Microsimulation Model
A microsimulation process was presented above as an iterative process at an individual level over the model's time horizon. Because of the causal dependence of future events on past event histories in the simulation, temporal iterations in the model cannot be easily vectorized. However, the repetitive process of a microsimulation across the individuals can be intuitively represented in a vectorized form. In this case, at each time iteration, all simulated individuals are transitioned simultaneously through the model. Vectorization can improve computational performance but often results in decision models with high-dimensionality components. For example, what was a vector of transition probabilities for an individual on a given point in time will become a matrix of probabilities, with the number of individuals in rows and the number of states in columns. Such higher dimensionality sometimes increases the complexity of the model structure. A frequently used tool in vectorization is linear algebra, as it can provide a convenient way of performing operations in a vector or matrix scale. Although linear algebra can facilitate quick calculations, it can also generate more complex coding and larger matrices that will require more computer memory. Hence, with vectorization, modelers must achieve a balance between conceptual complexity, memory, and computational efficiency.
Vectorization can be achieved in the context of our microsimulation example by extending the dimension of the health state sampling process. The function sample() used in this tutorial can support a vectorized solution only if the state transition probabilities are the same across individuals. However, in a microsimulation context, individuals' risk often depends on a number of individual-specific characteristics, which restrict us from using the sample() function on a vectorized context. To overcome this, and take advantage of vectorization solutions, we developed the samplev() function by modifying a random number generating function for multinomial variables from the Hmisc package. 32 The modification allows for a health state-specific vectorization solution based on vectors of random numbers generated from a U(0,1) distribution. The samplev() function randomly draws the state name at t + 1 based on the probability of each individual occupying each state at t + 1: The microsimulation results were generated by setting the random seed to 1 at the beginning of the simulation. Monte Carlo standard error in brackets.
To make use of the samplev() function, the Probs() function must also be modified to return a matrix of transition probabilities for the whole cohort rather than a vector of probabilities for a single individual at a time. The output of the modified Probs() function is therefore a matrix of size ni 3 ns. Because the samplev() function samples the name of the future states of individuals conditional on their probability of experiencing these states, state names are required as column names. In Appendix D, the code with all necessary modifications is presented.
The new samplev() function achieves a 97% reduction in the time needed to run the analysis (Table 4 ). The results in Table 4 are a time comparison, between the iterative standard approach for the simple Sick-Sicker model using the sample() function (Appendix A) and the vectorized approach for the simple Sick-Sicker model using the samplev() function (Appendix D). The time shown is the time (average of 3 runs) it takes to run the model for both the treatment and no treatment arm using the sample() or samplev() function.
Discussion
This tutorial provides guidance on the implementation of a microsimulation model using a programming language such as R. We outline the conceptual steps involved and provide an algorithm to operationalize these steps using a programming language. In addition, the tutorial illustrates an implementation of microsimulation models in R and presentation of the results in graphical form. This tutorial focuses on the implementation rather than the conceptualization of a microsimulation model. For interested readers, Roberts and others present recommendations and best practices regarding the process of decision model conceptualization. 33 In this paper, we focus on state-transition models with discrete time intervals. Another class of models consider time as continuous and simulate discrete events. Researchers interested in the implementation of discrete event simulation models might benefit from making themselves familiar with the simmer package. The core of the simmer package is written in C++ with automatic monitoring capabilities, which makes it a fast and robust framework to develop DES models and continuous time Markov models. 34 There are limited examples in the literature where researchers relied on R to build a microsimulation model for health decision making. However, most of these examples have appeared recently, which is consistent with the observed trend of a recent increase in the use of R in health decision modeling. 19 Manca and others published an early example of a microsimulation model built in R 35 and Choi and others more recently published a hypertension, stroke, and myocardial infarction microsimulation model. 36 For 2 other microsimulation models, MILC and CANTRANCE, the authors created R packages, which include all components of the model. 37, 38 Thus, R can be used not only to develop the model but also to provide an open-source platform for distributing the model to other users.
Building a microsimulation model in a programming language such as R has several advantages. Models are written in script form, which facilitates readability and reproducibility. The fact that R is open-source and freely available increases transparency and reproducibility of the analysis. In addition, due to R's architecture, efficient computational performance can be achieved. The output obtained from the model in R is not limited to the output generated by the proprietary software; it is possible to extract every specific outcome estimate (e.g., incidence, prevalence, and average time spent in a certain state). However, decisions on the generated output should be limited to only what is ultimately necessary for the analysis to minimize computational and memory storage demands. Finally, statistical analyses performed to provide input to the decision model could be embedded directly within the decision model. R may not always be the most appropriate platform, depending on the nature of the microsimulation model and the skills of the researchers. R is also not necessarily an ideal language for computationally intensive processes. Other programming languages, such as C/C++ or Fortran, may achieve significantly better performance. Combining the strengths of different languages is sometimes possible. For example, the package Rcpp makes it possible to interface C++ code in R functions and packages. 39 The flexibility of R implies that there can be multiple approaches to the operationalization of a microsimulation model. This tutorial provides one such approach but is not necessarily the most efficient. The implementation of the Sick-Sicker model was developed with a focus on clarity rather than computational efficiency. For example, one could employ matrix operations more extensively rather than relying on iterative or logical procedures. Avoiding iterative loops through vectorization in R can increase efficiency by multifold, 40 as confirmed by our results (Table 4) . When iterative loops are inevitable, the use of parallel processing can drastically improve computational times for iterative procedures. Alternatively, a microsimulation model in R can be developed using object-oriented programming with S4 or References Classes. Under this approach, simulated individuals, together with their characteristics, are encoded as a class and followed over time. In such a modeling approach, interaction between individuals can be incorporated in a more straightforward manner. Implementation of an objected-oriented microsimulation in R can be facilitated through the simecol package. 41 We encourage modelers to develop and distribute implementations that are more efficient than the one presented in this tutorial. We are also in the process of developing an additional tutorial on advanced methods around microsimulation using R. This upcoming tutorial will have a strong focus on computational efficiency. However, the modeler should also be aware of the tradeoff between the time savings associated with an efficient algorithm and the time investment required to achieve such efficiency. One way to reduce computational time in microsimulation models is the use of parallel processing techniques. Most modern computers are equipped with multi-core processors, which increase significantly their computational power. However, by default, R uses only a single core, thereby limiting its computational capacity. With the use of appropriate packages (e.g., parallel) R can achieve parallel processing capabilities, and thereby drastically reduce computational times. 42 One caveat of parallel processing is that the interaction of R with each of the core processors is time consuming, and modelers should be aware of this when employing parallel processing techniques. Overall, it is important that the additional complexity and flexibility introduced using a programming language be justified by the complexity needed to answer the research question.
There is always a degree of uncertainty in the parameter values used in health decision models. Such parameter uncertainty can be incorporated in a decision model via probabilistic sensitivity analysis (PSA; secondorder Monte Carlo simulation). 7, 43 The microsimulation approach presented above is only limited to the random variation of the individuals (first-order uncertainty) and ignores any parameter uncertainty. Efficient programming is particularly important in models that incorporate both individual variation and parameter uncertainty. Models where PSA is incorporated will require particularly long computational times. Using efficient methods when conducting PSA in R is a topic of relevance to any form of decision analysis. Therefore, we have started to prepare a separate tutorial on incorporating sensitivity analysis in decision modeling using R.
In summary, R is increasingly used for building simulation models in health decision sciences; however, information on how to perform these simulations is lacking. This tutorial provides a step-by-step guide to implementing a microsimulation model in R with the aim of supporting health decision scientists who are new to highlevel programming languages to develop models in a more flexible, open-source and transparent manner, and encouraging increased transparency and reproducibility in health decision sciences. In subsequent tutorials, and as part of the Decision Analysis in R for Technologies in Health (DARTH) group efforts, we will expand on model optimization, calibration, and value of information analysis among other topics. Future code updates will be placed on our GitHub https://github.com/ DARTH-git/Microsimulation-tutorial.
